Key clinical point: Insurers are spending more money for chemotherapy in outpatient hospital departments than physician offices.

Major finding: Total reimbursement during the 6-month treatment episode was lower in offices ($43,700) than in hospital outpatient departments ($84,660).

Study details: An examination of claims data from 283,502 patients who initiated treatment with infused chemotherapy and remained enrolled continuously for 6 months between Jan. 1, 2004, and Dec. 31, 2014.

Disclosures: The researchers reported having no financial conflicts of interest.

Read the full article.